Serial monitoring of BCR-ABL by peripheral blood real-time polymerase chain reaction predicts the marrow cytogenetic response to imatinib mesylate in chronic myeloid leukaemia-Reference-Cited by-同舟云学术

Serial monitoring of BCR-ABL by peripheral blood real-time polymerase chain reaction predicts the marrow cytogenetic response to imatinib mesylate in chronic myeloid leukaemia

Published:2002-08-15 Issue:3 Volume:118 Page:771-777
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Wang Lihui,Pearson Kevin,Pillitteri Lynne,Ferguson Julia E.,Clark Richard E.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2002.03705.x/fullpdf

Reference35 articles.

1. UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response;Allan;Lancet,1995

2. Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia;Amabile;Haematologica,2001

3. Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labelled probes;Bolufer;Haematologica,2000

4. Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics;Branford;British Journal of Haematology,1999

5. Molecular status of individual CFU-GM colonies derived from chemotherapy-mobilised peripheral blood stem cells in chronic myeloid leukaemia;Broughton;Genes Chromosomes and Cancer,1997

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of 3-month cytogenetic and molecular assays for early assessment of long-term clinical impact after BCR-ABL1 tyrosine kinase inhibitor treatment in chronic myeloid leukemia;Leukemia Research;2022-01

2. Multiplex technologies for the assessment of minimal residual disease and low‐level mutation detection in leukaemia: mass spectrometry versus next‐generation sequencing;British Journal of Haematology;2021-06-14

3. New Tool for Monitoring Molecular Response in Patients With Chronic Myeloid Leukemia;Applied Immunohistochemistry & Molecular Morphology;2019-01

4. Impact of the BCR - ABL1 fusion transcripts on different responses to Imatinib and disease recurrence in Iranian patients with Chronic Myeloid Leukemia;Gene;2017-09

5. Monitoring and defining early response: Where to draw the line?;Best Practice & Research Clinical Haematology;2016-09